藥物成份

共有 21098 個藥物成份

CUPRIC SULFATE, PENTAHYDRATE 12.3MMOL/L

• 關聯藥證數量: 1

CURCUMA EXTRACT

• 關聯藥證數量: 1

CUTTLEFISH BONE POWDER

• 關聯藥證數量: 1

CYANIN T7

• 關聯藥證數量: 1

CYANOCOBALAMIN (0.1% IN GEL)

• 關聯藥證數量: 1

CYANOCOBALAMIN (0.1% IN GELATIN)

• 關聯藥證數量: 1

CYANOCOBALAMIN (1% IN GELATIN)

• 關聯藥證數量: 1

CYANOCOBALAMIN (ANHYDROUS)

• 關聯藥證數量: 1

CYANOCOBALAMIN 0.1% IN DICALCIUM PHOSPHATE

• 關聯藥證數量: 1

CYANOCOBALAMIN 0.1% IN GEL

• 關聯藥證數量: 1

CYANOCOBALAMIN 0.1% IN GELATIN

• 關聯藥證數量: 1

CYANOCOBALAMIN 1% IN DICALCIUM PHOSPHATE

• 關聯藥證數量: 1

CYANOCOBALAMIN 1% IN GELATIN

• 關聯藥證數量: 1

CYANOCOBALAMIN 96.0%-102.0%

• 關聯藥證數量: 1

CYANOCOBALAMIN ON DICAL

• 關聯藥證數量: 1

CYANOCOMPLEX

• 關聯藥證數量: 1

CYCLEXEDRINE (B-CYCLOHEXYL ISOPROPYLMETHYLAMINE)

• 關聯藥證數量: 1

CYCLIZINE

• 關聯藥證數量: 1

CYCLO-Trac SP NSB ImmunoSep: Donkey anti-mouse serum/normal mouse serum premix is diluted in phosphate-buffered saline containing 0.08% sodium azide and a surfactant. Blue dye is added.\nCYCLO-Trac SP Calibrators (0-6): Cyclosporine-free serum cotains 0.1% sodium azide and a surfactant. Six cyclosporine calibrators, at nominal concentrations ranging from 0-1200 ng/ml, are prediluted in human serum.\nAnti-CYCLO-Trac SP ImmunoSep: Monoclonal mouse anti-cyclosporine antibody and donkey anti-mouse/normal mouse serum premix is diluted in phosphate-buffered saline containing 0.08% sodium azide and a surfactant.\n125I CYCLO-Trac SP: A derivative of cyclosporine is labeled with iodine-125 and diluted in citrate-EDTA buffer which contains 0.05% sodium azide, human serum and a surfactant. Red dye is added.\nCYCLO-Trac SP Controls (level 1 and level 2): Ranges for each lot are printed on the control vials included with each kit. 0.1% sodium azide and other stabilizers are added.\n

• 關聯藥證數量: 1

CYCLOBARBITAL CALCIUM

• 關聯藥證數量: 1

CYCLOBUTYROL (CALCIUM)

• 關聯藥證數量: 1

CYCLOFENIL

• 關聯藥證數量: 1

CYCLONIUM IODIDE (OXAPIUM IODIDE)

• 關聯藥證數量: 1

CYCLOPENTYLALLYLBARBITURIC ACID

• 關聯藥證數量: 1

CYCLOPHOSPHAMIDE ANHYDROUS

• 關聯藥證數量: 1

CYCLOPYRABITAL (CYCLOBARBITAL + AMINOPYRINE)

• 關聯藥證數量: 1

CYCLOSERINE D-

• 關聯藥證數量: 1

CYCOTIAMINE HCL

• 關聯藥證數量: 1

CYPERUS POWDERED

• 關聯藥證數量: 1

CYPERUS RHIZOME

• 關聯藥證數量: 1

CYPRESS OIL

• 關聯藥證數量: 1

CYSTEINE L- ETHYLESTER HCL

• 關聯藥證數量: 1

CYSTEINE L-(HCL ANHYDROUS)

• 關聯藥證數量: 1

CYTIDLIC ACID

• 關聯藥證數量: 1

CYTO-STAT/COULTER CLONE MsIgG1-RD1/MsIgG1-FITC. Antibodies:Specificity Non Applicable Non Applicable.Clone 2T8-2F5 2T8-2F5.Hybridoma NS-1xBALB/c NS-1xBALB/c.Immunogen Non Applicable Non Applicable.Ig Chain IgG1 IgG1.Species Mouse Mouse.Source Conditioned media Conditioned media.Purfication Affinity Chromatography Affinity chromatography.The concentration of nonantibody reagents is 0.2% BSA, 0.01 M potassium phosphate, 0.15 M NaCl, 0.1% NaN3.

• 關聯藥證數量: 1

CYTO-STAT/COULTER CLONET8-RD1/T4-FITC Monoclonal Antibodies, PN 6604614-50 tests (0.5 mL)\nAntibodies: CLONE 1-CD8, SFCI21Thy2D3 Hybridoma.\n CLONE 2-CD4, SFCI12T4D11 Hybridoma.\n

• 關聯藥證數量: 1

CaCl2.......0.025mol/L/

• 關聯藥證數量: 1

CaR1： Monoethanolamine 1.5 mol/L\n Baric acid 100 mmol/L\nCaR2：0-Cresolphthalein complexon 0.4 mmol/L\n 8-Hydroxyquinoline 52 mmol/L

• 關聯藥證數量: 1

Cabazitaxel contains not less than 98.0 percent and not more than 102.0 percent of C45H57NO14, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cabergoline contains not less than 98.0% and not more than 102.0% of C26H37N5O2, calculated on anhydrous substance.

• 關聯藥證數量: 1

Cable (Optional)

• 關聯藥證數量: 1

Cabotegravir

• 關聯藥證數量: 1

Cabotegravir sodium

• 關聯藥證數量: 1

Caffeine Anhydrous contains not less than 98.5% and not more than 101.0% of C8H10N4O2 calculated on the the dried basis.

• 關聯藥證數量: 1

Caffeine Monohydrate contains not less than 98.5% and not more than 101.5% of C8H10N4O2 calculated on the anhydrous basis.

• 關聯藥證數量: 1

Caffeine contains not less than 98.5% and not more than 101.0% of C8H10N4O2, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Caffeine contains not less than 98.5% and not more than than the equivalent of 101.5% of C8H10N4O2, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Caffeine contains not less than 98.5% and not more than the equivalent of 101.5% of C8H10N4O2，calculated with reference to the dried substance.

• 關聯藥證數量: 1

Caffeine is anhydrous or contains one molecule of water of hydration. It contains not less than 98.5% and not more than 101% of C8H10N4O2, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Caffeine\n3,5-dichlorophenyldiazonium tetrafluoroborate\nSurfactant

• 關聯藥證數量: 1

Cal/Wash: 160 mM Na+, 2mM K+, 130 mM Cl-\nSlope: 120 mM Na+, 8 mM K+, 80 mM Cl-, 40 mM tCO2\ntCO2 Release: 0.5 M Lactic acid\nUrine Diluent Reagent: 120 mM Na+, 10 mM K+, 70 mM Cl-\nUrine Cal Reagent: 96 mM Na+, 8 mM K+, 56 mM Cl-\nUrine Slope Reagent: 156 mM Na+, 38 mM K+, 116 mM Cl-

• 關聯藥證數量: 1

Cal1 PCT calibrator 1 (white cap), 1 bottle (lyophilized) for 4 mL: PCT (recombinant) approx. 0.10 ng/mL in a human serum matrix; preservative.\n

• 關聯藥證數量: 1

Cal1 Anti-CCP calibrator 1 (white cap), 2 bottles (lyophilized) for 1.0 mL each: Anti-CCP antibodies (human) approx. 20 U/mL in a human serum matrix.

• 關聯藥證數量: 1

Cal1 Negative calibrator 1, 2 bottles of 1.0 mL each:\nHuman serum, non-reactive for anti-Rubella IgG; preservative.\nCal2 Positive calibrator 2, 2 bottles of 1.0 mL each:\nAnti-Rubella IgG approx. 400 IU/mL in human serum; preservative.

• 關聯藥證數量: 1

Cal1: 2 bottles, each for 1.0 mL of calibrator 1\nCal2: 2 bottles, each for 1.0 mL of calibrator 2

• 關聯藥證數量: 1

Cal2 PCT calibrator 2 (black cap), 1 bottle (lyophilized) for 4 mL: PCT (recombinant) approx. 54 ng/mL in a human serum matrix; preservative.\n

• 關聯藥證數量: 1

Cal2 Anti-CCP calibrator 2 (black cap), 2 bottles (lyophilized) for 1.0 mL each: Anti-CCP antibodies (human) approx. 200 U/mL in a human serum matrix.

• 關聯藥證數量: 1

CalSet\n？ACTH Cal1: 2 bottles, each for 1.0 mL of calibrator 1\n？ACTH Cal2: 2 bottles, each for 1.0 mL of calibrator 2\nACTH (synthetic) in two concentration ranges (approx. 15 pg/mL and approx. 120 pg/mL) in an equine serum matrix.

• 關聯藥證數量: 1

Calcipotriol Anhydrous contains not less than 95.5% and not more than 102.0% of C27H40O3, calculated on anhydrous substance.

• 關聯藥證數量: 1

Calcipotriol Monohydrate 95.5 - 102.0 % (calculated on dried basis.)

• 關聯藥證數量: 1

Calcipotriol Monohydrate contains not less than 95.5% and not more than 102.0% of C27H40O3‧H2O, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Calcipotriol monohydrate contains 95.5%~102.0% (as anhydrous basis)

• 關聯藥證數量: 1

Calcitonin Bead Pack (L2CL12)：beads, coated with monoclonal murine anti-calcitonin.\nCalcitonin Reagent Wedge (L2CLA2)：alkaline phosphatase (bovine calf intestine) conjugated to polyclonal goat anti-calcitonin, in a protein buffer.\nCalcitonin Adjustors (LCLL, LCLH)：(Low and High) of lyophilized calcitonin, in a protein/buffer matrix.

• 關聯藥證數量: 1

Calcitonin Bead Pack(L2CL12)：coated with monoclonal murine anti-calcitonin.\nCalcitonin Reagent Wedge(L2CLA2)：11.5 mL alkaline phosphatase(bovine calf intestine)conjugated to polyclonal goat anticalcitonin.\nCalcitonin Adjustors (LCLL,LCLH)：Two vials(Low and High) of lyophilized calcitonin.

• 關聯藥證數量: 1

Calcitonin Calibrator 0: BSA-borate buffer with sodium azide (0.25%) added.\nCalcitonin II Calibrator: human synthetic calcitonin, at a nominal concentration of 1000 pg/ml, is diluted in BSA-borate buffer.\nCalcitonin Antiserum: goat anti-calcitonin serum is diluted in BSA-borate buffer.\n125I Calcitonin: synthetic human calcitonin is labeled with iodine-125 and diluted in BSA-borate-EDTA buffer.\nCalcitonin Precipitating Complex: normal goat serum, pre-precipitated with donkey anti-goat serum and polyethylene glycol (PEG), is diluted in BSA-borate buffer.\nCalcitonin Controls (Level 1 and 2): human serum is spiked, if necessary, with the appropriate amount of synthetic human calcitonin to obtain a concentration within a specified range.\n

• 關聯藥證數量: 1

Calcitriol contains not less than 97.0% and not more than 103.0% of C27H44O3

• 關聯藥證數量: 1

Calcitriol contains not less than 97.0% and not more than 103.0% of C27H44O3, calculated on anhydrous substance.

• 關聯藥證數量: 1

Calcium Acetate contains not less than 99.0% and not more than 100.5% of C4H6CaO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Calcium Carbonate content: 98.5 per cent to 100.5 per cent (dried substance).

• 關聯藥證數量: 1

Calcium Carbonate CaCO3：0.25 g/L

• 關聯藥證數量: 1

Calcium Carbonate Granulation

• 關聯藥證數量: 1

Calcium Carbonate contains not less than 98.5% and not more than 101.0% of CaCO3, calculated on the dried basis.

• 關聯藥證數量: 1

Calcium Carbonate, contains calcium equivalent to not less than 98.0% and not more than 100.5% of CaCO3.

• 關聯藥證數量: 1

Calcium Carbonate, contains calcium equivalent to not less than 98.5% and not more than 100.5% of CaCO3, calculated on the dried basis.

• 關聯藥證數量: 1

Calcium Chloride 0.025 M.

• 關聯藥證數量: 1

Calcium Chloride-2-Hydrate contains not less than 99.0% and not more than 103.0% of CaCl2‧2H2O

• 關聯藥證數量: 1

Calcium Folinate (Leucovorin Calcium) contains not less than 97.0% and not more than 102.0% of C20H21CaN7O7, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Calcium Folinate contains not less than 97.0% and not more than 102.0% of C20H21CaN7O7, and contains 7.54% to 8.14% of Calcium, both calculated on anhydrous substance.

• 關聯藥證數量: 1

Calcium Folinate contains not less than 97.0% and not more than 102.0% of C20H21CaN7O7, calculated on anhydrous substance.

• 關聯藥證數量: 1

Calcium Folinate contains not less than 97.0% and not more than the equivalent of 102.0% of calcium (2S)-2-{[4-[[[(6RS)-2-amino-5-formy-4-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl]amino]benzoyl]amino} pentanedioate and not less than 7.54 percent and not more than the equivalent of 8.14 percent of Ca, both calculated with reference to the anhydrous and solvent-free substance.

• 關聯藥證數量: 1

Calcium HRII:1. Buffer Monoethanolamine buffer 0.88 mol/L (pH 11.0)2. Color OCPC 0.1 mmol/L Quinolinol (8-Hydroxyquinoline) 11 mmol/LCalcium E-HA:1. Buffer 3.3 mol/L Monoethanolamin buffer, PH 12.02. Color appearance testingMXB 0.29 mmol/L8-Quinolinol 31 mmol/L

• 關聯藥證數量: 1

Calcium Hydroxylapatite(75-125 microns) ..............30%\nSterile Water for Injection, U.S.P. .........................52%\nGlycerin, U.S.P. .................................................15%\nSodium Carboxymethylcellulose, U.S.P. .................3%

• 關聯藥證數量: 1

Calcium Polystyrene Sulfonate (eq. to Calcium polystyrene sulphonate), C8H7CaO3S+, is a cation-exchange resin prepared in the calcium form containing not less than 6.5% w/w and not more than 9.5% w/w of calcium, calculated with reference to the dried substance. Each g exchanges not less than 1.3 mEq and not more than 2.0mEq of potassium, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Calcium Sennoside 90TPC contains not less than 90.0% and not more than 110.0% of C42H36O20Ca.

• 關聯藥證數量: 1

Calcium Sennosides 60TPC contains not less than 60.0% of C42H36O20Ca, calculated on the dried basis.

• 關聯藥證數量: 1

Calcium acetate contains assay (titration) 99.0%~100.5% (on Anhydrous basis)

• 關聯藥證數量: 1

Calcium carbonate 25mg/L; Potassium dihydrogenphosphate 176mg/L; Magnesium nitrate 0.012mmol/L; Iron(II) ammonium sulfate hexahydrate 35.2mg/L; Glucose 2.0g/L; Creatinine 30mg/L; Preservative in suitable quantity.

• 關聯藥證數量: 1

Calcium chloride dihydrate contains less than 97.0% and not more than 103.0% of CaCl2．2H2O

• 關聯藥證數量: 1

Calcium hydroxide.....34%\nPhosphoric acid.....13.8%\nWater.....82.8%\n以下空白

• 關聯藥證數量: 1

Calcium-D-Pantothenate contains not less than 98.0% and not more than 101.0% of C18H32CaN2O10, calculated on dried basis.

• 關聯藥證數量: 1

Calibration plasma：10 X 1ml vials of lyophilized human plasma containing buffer.

• 關聯藥證數量: 1

Calibrator #1：0.20% w/v potassium phosphate monobasic; 0.18% w/v sodium chloride; 0.10% w/v sodium acetate; 0.80% w/v urea; with preservative.\nCalibrator #2：2.00% w/v potassium phosphate monobasic; 0.18% w/v sodium chloride; 1.00% w/v sodium acetate; 8.00% w/v urea; with preservative.\nCalibrator #3：0.50% w/v potassium phosphate monobasic; 0.45% w/v sodium chloride; 0.25% w/v sodium acetate; 2.00% w/v urea; 2.00% w/v glucose; 0.50% w/v bovine albumin; with preservative.\nCalibrator #4：0.01% w/v polymer beads; with surfactant and 0.05% w/v sodium azide as preservative\n

• 關聯藥證數量: 1

Calibrator 0: lyophilized reagent, ACTH-free human plasma.\nACTH Calibrators (A-E): lyophilized reagent, ACTH calibrators (porcine), at nominal concentrations ranging from 20-500 pg/mL (4.5-112 picomoles/L).\nACTH Antiserum: lyophilized reagent, Rabbit anti-ACTH serum diluted in BSA-borate buffer with Thimerosal.\nI-125 ACTH: lyophilized reagent, Synthetic ACTH labeled with iodine-125, diluted in BSA-borated-EDTA buffer with Thimerosal.\nPrecipitating Complex (GAR-PPT): lyophilized reagent, Normal rabbit serum, pre-precipitated with goat anti-rabbit serum and polyethylene glycol (PEG), is diluted in BSA-borate buffer with Thimerosal.\nACTH Control (Level 1 and 2): lyophilized reagent, Human plasma spiked, if necessary, with the appropriate amount of synthetic ACTH to obtain a concentrate within a specified range.

• 關聯藥證數量: 1

Calibrator 1：(5 μg/mL) 2mL x 1\nCalibrator 2：(25 μg/mL) 2mL x 1\nCalibrator 3 ：(100 μg/mL) 2mL x 1\nCalibrator 4 ：(300 μg/mL) 2mL x 1\nCalibrator 5 ：(500 μg/mL) 2mL x 1

• 關聯藥證數量: 1

Calibrator 1：0.20 % w/v potassium phosphate monobasic, 0.18% w/v sodium chloride, 0.10% w/v sodium acetate, 0.80% w/v urea, preservative

• 關聯藥證數量: 1

Calibrator 2：2.00 % w/v potassium phosphate monobasic, 1.80% w/v sodium chloride, 1.00% w/v sodium acetate, 8.00% w/v urea, preservative

• 關聯藥證數量: 1

Calibrator 3：0.50 % w/v potassium phosphate monobasic, 0.45% w/v sodium chloride, 0.25% w/v sodium acetate, 2.00% w/v urea, 2.00% w/v glucose, 0.50% w/v bovine albumin, preservative

• 關聯藥證數量: 1

Calibrator 4：0.01% w/v polymer beads, surfactant, 0.05% w/v sodium azide

• 關聯藥證數量: 1

Calibrator A Sodium Chloride 150mM 1x1ml\n Sodium Azide 0.1%\nCalibrator B-F Human Serum 5x1ml\n Sodium Azide 0.1%

• 關聯藥證數量: 1

Calibrator A：150mM Sodium Chloride 1x1 ml\nCalibrator B-F Human Prealbumin 5x1 ml\n150mM Sodium Chloride

• 關聯藥證數量: 1